Invention Grant
- Patent Title: Methods of treating cancer using a combination of an immunomodulatory compound and an artemisinin or a derivative thereof
- Patent Title (中): 使用免疫调节化合物和青蒿素或其衍生物的组合治疗癌症的方法
-
Application No.: US13520675Application Date: 2011-01-05
-
Publication No.: US09226913B2Publication Date: 2016-01-05
- Inventor: Angus Dalgleish , Andrew Gravett , Wai Liu
- Applicant: Angus Dalgleish , Andrew Gravett , Wai Liu
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- International Application: PCT/US2011/020160 WO 20110105
- International Announcement: WO2011/084968 WO 20110714
- Main IPC: A61K31/366
- IPC: A61K31/366 ; A61K31/7068 ; A61K31/45 ; A61K31/4015 ; A61K31/282 ; A61K31/357 ; A61K31/4035 ; A61K31/454 ; A61K31/541 ; A61K45/06
Abstract:
Provided herein are methods for treating cancers by administering immunomodulatory compounds in combination with artemisinin or a derivative thereof. In particular, methods for treating cancers by administering lenalidomide in combination with artemisinin or a derivative thereof are provided.
Public/Granted literature
Information query
